LYTIR

Company · INCY

Incyte Corporation

Name as listed on its exchange; filed with the SEC as INCYTE CORP.

Nasdaq's symbol directory lists INCY on Nasdaq as “Incyte Corporation - Common Stock”.

In the 12 months to Nov 19, 2026: insiders sold on 18 occasions ($49.0M); 17 planned-sale notices; 1 filing by holders of 5% or more; 3 congressional trade disclosures; 6 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 35

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $49.0M in total.Jun: Insider sales $264KJul: Insider sales $10.4MAug: Insider sales $5.0MSep: Insider sales $2.8MOct: Insider sales $298KNov: Insider sales $30.2MDecJanFebMarAprMayJunJulAugSepOctNov$30.2M
Insider purchases above the line: $0Insider sales below: $49.0M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Stein Steven H, CMO & Head of Late-Stage Dev. sold on 4 days all under a 10b5-1 plan latest Nov 16, 2026 sold $31.9M
  2. CAGNONI PABLO J, President, Global Head of R&D sold on 7 days all under a 10b5-1 plan latest Nov 16, 2026 sold $9.3M
  3. Mayes Patrick A, EVP & Chief Scientific Officer sold on 3 days all under a 10b5-1 plan latest Aug 5, 2026 sold $6.0M
  4. Heeson Lee, EVP, Head of Incyte Intl sold on 1 day all under a 10b5-1 plan latest Nov 13, 2026 sold $1.3M
  5. Tray Thomas, Principal Accounting Officer sold on 2 days all under a 10b5-1 plan latest Nov 3, 2026 sold $336K
  6. Issa Mohamed Khairie, EVP, Head of U.S. Commercial sold on 1 day all under a 10b5-1 plan latest Jul 16, 2026 sold $126K
Every trade (18)
  1. SELLCAGNONI PABLO J, President, Global Head of R&D sold Nov 16, 2026 2,642 shares 2 legs combined 10b5-1 plan (scheduled) filing $320K
  2. SELLStein Steven H, CMO & Head of Late-Stage Dev. sold Nov 16, 2026 576 shares 10b5-1 plan (scheduled) filing $70K
  3. SELLHeeson Lee, EVP, Head of Incyte Intl sold Nov 13, 2026 10,694 shares 5 legs combined 10b5-1 plan (scheduled) filing $1.3M
  4. SELLStein Steven H, CMO & Head of Late-Stage Dev. sold Nov 6, 2026 240,193 shares 5 legs combined 10b5-1 plan (scheduled) filing $28.4M
  5. SELLTray Thomas, Principal Accounting Officer sold Nov 3, 2026 610 shares 10b5-1 plan (scheduled) filing $73K
  6. SELLCAGNONI PABLO J, President, Global Head of R&D sold Oct 15, 2026 2,642 shares 10b5-1 plan (scheduled) filing $298K
  7. SELLCAGNONI PABLO J, President, Global Head of R&D sold Sep 15, 2026 23,218 shares 2 legs combined 10b5-1 plan (scheduled) filing $2.8M
  8. SELLCAGNONI PABLO J, President, Global Head of R&D sold Aug 19, 2026 10,801 shares 10b5-1 plan (scheduled) filing $1.4M
  9. SELLCAGNONI PABLO J, President, Global Head of R&D sold Aug 12, 2026 10,803 shares 10b5-1 plan (scheduled) filing $1.3M
  10. SELLCAGNONI PABLO J, President, Global Head of R&D sold Aug 5, 2026 10,640 shares 10b5-1 plan (scheduled) filing $1.3M
  11. SELLMayes Patrick A, EVP & Chief Scientific Officer sold Aug 5, 2026 2,207 shares 10b5-1 plan (scheduled) filing $274K
  12. SELLMayes Patrick A, EVP & Chief Scientific Officer sold Aug 3, 2026 6,055 shares 10b5-1 plan (scheduled) filing $729K
  13. SELLMayes Patrick A, EVP & Chief Scientific Officer sold Jul 31, 2026 41,899 shares 11 legs combined 10b5-1 plan (scheduled) filing $5.0M
  14. SELLCAGNONI PABLO J, President, Global Head of R&D sold Jul 31, 2026 15,888 shares 10b5-1 plan (scheduled) filing $1.9M
  15. SELLStein Steven H, CMO & Head of Late-Stage Dev. sold Jul 16, 2026 1,877 shares 10b5-1 plan (scheduled) filing $215K
  16. SELLIssa Mohamed Khairie, EVP, Head of U.S. Commercial sold Jul 16, 2026 1,093 shares 10b5-1 plan (scheduled) filing $126K
  17. SELLStein Steven H, CMO & Head of Late-Stage Dev. sold Jul 15, 2026 28,237 shares 10b5-1 plan (scheduled) filing $3.2M
  18. SELLTray Thomas, Principal Accounting Officer sold Jun 4, 2026 2,639 shares 10b5-1 plan (scheduled) filing $264K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. PABLO CAGNONI filed Nov 16, 2026 Officer 2,642 shares planned sale date 11/16/2026 filing $320K
  2. STEVEN STEIN filed Nov 16, 2026 Officer 1,958 shares planned sale date 11/16/2026 filing $237K
  3. LEE HEESON filed Nov 13, 2026 Officer 10,694 shares planned sale date 11/13/2026 filing $1.3M
  4. STEVEN STEIN filed Nov 6, 2026 Officer 240,193 shares planned sale date 11/06/2026 filing $28.3M
  5. THOMAS TRAY filed Nov 3, 2026 Officer 610 shares planned sale date 11/03/2026 filing $73K
  6. PABLO CAGNONI filed Oct 15, 2026 Officer 2,642 shares planned sale date 10/15/2026 filing $298K
  7. PABLO CAGNONI filed Sep 15, 2026 Officer 23,218 shares planned sale date 09/15/2026 filing $2.8M
  8. PABLO CAGNONI filed Aug 19, 2026 Officer 10,801 shares planned sale date 08/19/2026 filing $1.4M
  9. PABLO CAGNONI filed Aug 12, 2026 Officer 10,803 shares planned sale date 08/12/2026 filing $1.3M
  10. PABLO CAGNONI filed Aug 5, 2026 Officer 10,640 shares planned sale date 08/05/2026 filing $1.3M
  11. PATRICK A MAYES filed Aug 5, 2026 Officer 2,207 shares planned sale date 08/05/2026 filing $274K
  12. PATRICK A MAYES filed Aug 3, 2026 Officer 6,055 shares planned sale date 08/03/2026 filing $729K
  13. PATRICK A MAYES filed Jul 31, 2026 Officer 41,899 shares planned sale date 07/31/2026 filing $5.0M
  14. PABLO CAGNONI filed Jul 31, 2026 Officer 15,888 shares planned sale date 07/31/2026 filing $1.9M
  15. STEVEN STEIN filed Jul 16, 2026 Officer 1,877 shares planned sale date 07/16/2026 filing $215K
  16. MOHAMED ISSA filed Jul 16, 2026 Officer 1,093 shares planned sale date 07/16/2026 filing $126K
  17. STEVEN STEIN filed Jul 15, 2026 Officer 28,237 shares planned sale date 07/15/2026 filing $3.2M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Dodge & Cox filed Nov 12, 2026 Schedule 13G/A passive 10,064,186 shares filing 5%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Rohit Khanna (D-CA17): Purchase May 15, 2026 reported Jun 9, 2026 one of 504 trades the member reported that day House owner: spouse $1,001 - $15,000
  2. Rohit Khanna (D-CA17): Sale Mar 10, 2026 reported Apr 7, 2026 one of 274 trades the member reported that day House owner: spouse $1,001 - $15,000
  3. Rohit Khanna (D-CA17): Purchase Jan 29, 2026 reported Feb 6, 2026 one of 878 trades the member reported that day House owner: spouse $1,001 - $15,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Other events filing Nov 13, 2026
  2. Results of operations and financial condition filing Oct 29, 2026
  3. Other events filing Aug 31, 2026
  4. Results of operations and financial condition filing Jul 28, 2026
  5. Other events filing Jul 6, 2026
  6. Other events filing Jun 22, 2026

Lobbying · Senate LDA reports

Lobbying filed

6 quarterly lobbying reports for 2026 naming Incyte Corporation as the client: 1 filed by the company itself, 5 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.

  1. The company itself Q1 2026 filing $480K
  2. CHECKMATE GOVERNMENT RELATIONS Q1 2026 filing $110K
  3. TIBER CREEK GROUP Q1 2026 filing $80K
  4. AVENUE SOLUTIONS Q1 2026 filing $60K
  5. W STRATEGIES, LLC Q1 2026 filing $60K
  6. LMH STRATEGIC SOLUTIONS Q1 2026 filing $50K

Sources: SEC EDGAR (Forms 4, 144 and 8-K), Senate LDA lobbying reports and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.